NewAmsterdam Pharma Co N.V.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC NAMS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

265,199

Value ($000)

9,303

Weight

0.0%

2024 Q2 - 2025 Q4 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	9,303	0.0%	265,199	12/31/2025
2025 Q2	8/14/2025	5,810	0.0%	320,804	6/30/2025
2025 Q1	5/19/2025	5,898	0.0%	288,134	3/31/2025
2024 Q4	2/14/2025	6,517	0.0%	253,571	12/31/2024
2024 Q3	11/14/2024	3,972	0.0%	239,283	9/30/2024
2024 Q2	8/14/2024	345	0.0%	17,978	6/30/2024